Global Oxytocin Market Size (2024 - 2029)

The oxytocin market is anticipated to experience growth over the forecast period, driven by factors such as the increasing prevalence of pregnancy complications, rising global birth rates, and heightened awareness of induced labor and breastfeeding. The market's expansion is further supported by collaborative ventures and new developments in oxytocin applications, particularly in metabolic disorders and central nervous system conditions. Additionally, the hormone's role in pregnancy care, such as preventing postpartum hemorrhage, contributes to its market growth. However, challenges such as stringent regulations and high drug costs may impede the market's potential expansion.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Hormones Research Global Oxytocin Market Market Size

Market Size of Global Oxytocin Industry

Oxytocin Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 5.40 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Oxytocin Market Major Players

*Disclaimer: Major Players sorted in no particular order

Oxytocin Market Analysis

The oxytocin market is expected to record a CAGR of 5.4% over the forecast period.

COVID-19 significantly impacted the oxytocin market and the overall healthcare industry during the initial phase. For instance, as per the article published in May 2022 under the title "Oxytocin, the Panacea for Long-COVID? A Review", in the study," researchers evaluated the underlying mechanisms for long-COVID and how the oxytocinergic neurons are likely to be affected by SARS-CoV-2 leading to a reduction in plasma oxytocin (OXT). The study also identified a potential mechanism for long-COVID that involves OXT dysfunction. Furthermore, the article published in August 2021 titled" Covid and Oxytocin: Looking for Microbial Symbiosis' stated that the oxytocin hormone has anti-inflammatory and antioxidant protective effects and has received particular attention due to the pandemic of COVID-19. Hence, as per the factors mentioned above, COVID-19 significantly impacted the oxytocin market.

Factors driving the market growth include the increasing prevalence of pregnancy complications, rising births globally, and growing awareness of induced labor and breastfeeding. For instance, as per the December 2021 update from United Nations International Children's Emergency Fund (UNICEF), an estimated 140 million children were born in 2021. Furthermore, as per the August 2021 update from International Institute for Sustainable Development, the global population is projected to increase to 9.7 billion by 2050. This level represents a nearly 24% increase over 2020. Because of the increased birth rate and population levels, there is a high chance for growth of the oxytocin market since oxytocin is advised for antepartum and postpartum pregnancy.

Moreover, the presence of competitors, new developments associated with oxytocin, and collaborations boost the market growth. For instance, per the January 2021 update, Tonix Pharmaceuticals entered a licensing agreement with Katana Pharmaceuticals for its intranasal potentiated oxytocin to expand its use in metabolic disorders, especially insulin resistance, diabetes, and obesity. The licensing deal is an addition to the company's original purchase of oxytocin-potentiated therapy from Trigemina in June 2020, with preclinical data demonstrating the efficacy of the intranasal oxytocin product TNX-1900 in disorders of the central nervous system, with migraine chosen as the lead indication by Tonix. These oxytocin-related collaborative ventures and partnerships open the way for various indications, supporting the market's growth over the forecast period.

Furthermore, the application of oxytocin in pregnancy boosts the market growth, for instance, as per the article published in July 2020 titled "Role of Oxytocin in Prevention of Postpartum Hemorrhage in Unplanned Out-of-Hospital Deliveries Treated By Emergency Medical Services" in Finland, postpartum hemorrhage following unplanned out-of-hospital deliveries was prevented by intramuscular or intravenous oxytocin administration. Rising disposable incomes, especially in developing countries, increasing awareness regarding pregnancy care products among women, an increase in the literacy rate of women, and an increase in well-developed distribution channels for oxytocin products are the major factors driving the growth of the oxytocin market.

As per the factors above, the oxytocin market will likely grow over the forecast period. However, stringent regulations and the high cost of oxytocin drugs associated with the drug restrain the market growth.

Oxytocin Industry Segmentation

As per the scope of the report, oxytocin is a hormone made in the brain that plays a role in childbirth and lactation by causing muscles to contract in the uterus (womb) and the mammary glands in the breast. The Oxytocin Market is segmented by Indication (Antepartum, Postpartum), Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies) Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Indication
Antepartum
Postpartum
By Distribution Channel
Hospital Pharmacies
Drug Stores
Online Pharmacies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Oxytocin Market Size Summary

The oxytocin market is poised for growth, driven by factors such as the increasing prevalence of pregnancy complications, a rise in global birth rates, and heightened awareness of induced labor and breastfeeding. The market's expansion is further supported by the application of oxytocin in pregnancy, where it is used to enhance uterine contractions and prevent postpartum hemorrhage. The presence of competitors and collaborative ventures, such as licensing agreements and product developments, also contribute to the market's dynamic landscape. Despite the challenges posed by stringent regulations and high drug costs, the market is expected to benefit from ongoing research and development, as well as strategic mergers and acquisitions.

North America leads the oxytocin market, fueled by rising preterm births, fertility rates, and healthcare expenditure. The region's diverse birth populations and government initiatives to raise awareness about oxytocin's benefits and risks further bolster market growth. The competitive landscape is characterized by major players like Pfizer Inc., GlaxoSmithKline PLC, and Novartis AG, who are actively engaging in strategies to maintain their market shares. Recent developments, such as Tonix Pharmaceuticals' patent for intranasal oxytocin for pain treatment, highlight the ongoing innovation within the market. Overall, the oxytocin market is expected to experience significant growth over the forecast period, driven by both clinical applications and strategic industry movements.

Explore More

Global Oxytocin Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Pregnancy Complications

      2. 1.2.2 Rising Number of Births Globally

      3. 1.2.3 Growing Awareness of Induced Labor and Breastfeeding

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulations and High Cost of Oxytocin Drug

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Indication

      1. 2.1.1 Antepartum

      2. 2.1.2 Postpartum

    2. 2.2 By Distribution Channel

      1. 2.2.1 Hospital Pharmacies

      2. 2.2.2 Drug Stores

      3. 2.2.3 Online Pharmacies

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Oxytocin Market Size FAQs

The Global Oxytocin Market is projected to register a CAGR of 5.40% during the forecast period (2024-2029)

Pfizer Inc. , Weefsel Pharma, EVER Pharma, AdvaCare Pharma and Fresenius Kabi AG are the major companies operating in the Global Oxytocin Market.

Global Oxytocin Report Snapshots

Oxytocin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)